International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 137-144 , March 2007

Prognostic factors and determinants of fatal outcome due to bacterial meningitis in the Lazio region of Italy, 1996–2000

Received 4 August 2005 ,Revised 1 December 2005 ,Accepted 22 December 2005.

References 

  1. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick S, Caviness VS, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993;328:21–28
  2. Aronin SI, Peduzzi P, Quagliariello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998;129:862–869
  3. Kastenbauer S, Pfister H-W. Pneumococcal meningitis in adults. Spectrum of complications and prognostic factors in a series of 87 cases. Brain. 2003;126:1015–1025
  4. McMillan DA, Lin CY, Aronin SI, Quagliariello VJ. Community-acquired bacterial meningitis in adults: categorization of causes and timing of death. Clin Infect Dis. 2001;33:969–975
  5. Tang L-M, Chen S-T, Hsu W-C, Lyu R-K. Acute bacterial meningitis in adults: a hospital-based epidemiological study. Q J Med. 1999;92:719–725
  6. Barquet N, Domingo P, Caylà JA, Gonzales J, Rodrigo C, Fernandez-Viladrich P, et al. Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. JAMA. 1997;278:491–496
  7. Sàez-Llorens X, McCracken GH. Bacterial meningitis in children. Lancet. 2003;361:2139–2148
  8. Lu C-H, Huang C-R, Chang W-R, Chang C-J, Cheng B-C, Lee P-Y, et al. Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors. Clin Neurol Neurosurg. 2002;104:352–358
  9. Bi P, Parton KA, Whitby M. Co-existing conditions for deaths from infectious and parasitic diseases in Australia. Int J Infect Dis. 2004;8:121–125
  10. El Bushra HE, Hassan NMM, Al-Hamdan NA, Al-Jeffri MH, Turkistani AM, Al-Jumaily A, et al. Determinants of case fatality rates of meningococcal disease during outbreaks in Makkah, Saudi Arabia, 1987–97. Epidemiol Infect. 2000;125:555–560
  11. Begg N, Cartwright KA, Cohen J, Kaczmarski EB, Innes JA, Leen CLS, et al. Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. J Infect. 1999;39:1–15
  12. Booy R, Habibi P, Nadel S, de Munter C, Britto J, Morrison A, et al. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child. 2001;85:386–390
  13. Kilpi T, Anttila M, Kallio MJ, Peltola H. Severity of childhood bacterial meningitis and duration of illness before diagnosis. Lancet. 1991;338:406–409
  14. Faustini A, Fabrizi E, Sangalli M, Bordi E, Cipriani P, Fiscarelli E, et al. Role of laboratories in population-based surveillance of invasive diseases in Lazio, Italy, 1998–2000. Eur J Clin Microbiol Infect Dis. 2002;21:824–826
  15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–383
  16. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. N Engl J Med. 1997;337:970–976
  17. Goldacre MJ, Roberts SE, Yates D. Case fatality rates for meningococcal disease in an English population, 1963–98: database study. BMJ. 2003;327:596–597
  18. Moura AS, Pablos-Mendez A, Layton M, Weiss D. Epidemiology of meningococcal disease, New York city, 1989–2000. Emerg Infect Dis. 2003;9:355–361

PII: S1201-9712(06)00058-0

doi: 10.1016/j.ijid.2005.12.004

International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 137-144 , March 2007

Article Tools